Orsiro™ Drug Eluting Stent in Routine Clinical Practice (IRIS ORSIRO)

Seung-Jung Park

Status: Completed

Conditions: Coronary Artery Disease; Angioplasty, Transluminal, Percutaneous Coronary

Treatments: Device: Orsiro™ Drug Eluting Stent group

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT02039739

AMCCV2014-02

Details and patient eligibility

About

The purpose of this study is to evaluate effectiveness and safety of Orsiro™ Drug Eluting Stent in Routine Clinical Practice

Enrollment: 1,007 patients

Sex: All

Ages: 20+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age 20 and more
• Intervention with Orsiro™ Drug Eluting Stent
• Agreed with written informed consent form

Exclusion criteria

• Intervention with Orsiro™ drug eluting coronary stent and other drug eluting stent at the same time
• Life expectancy of 1year and under
• Cardiac shock

Trial design

1,007 participants in 1 patient group

Orsiro™ Drug Eluting Stent

Treatment:

Device: Orsiro™ Drug Eluting Stent group